S'abonner

Demographic and Regional Trends of Cardiovascular Diseases and Diabetes Mellitus-Related Mortality in the United States From 1999 to 2019 - 20/06/23

Doi : 10.1016/j.amjmed.2023.03.002 
Vardhmaan Jain, MD a, 1, Abdul Mannan Khan Minhas, MD b, 1, , Robert W. Ariss, MD c, Salik Nazir, MD d, Safi U. Khan, MD, MS e, Muhammad Shahzeb Khan, MD, MS f, Mahmoud Al Rifai, MD, MPH e, Erin Michos, MD g, Anurag Mehta, MD h, Arman Qamar, MD, MPH i, Elizabeth M. Vaughan, DO, MPH j, Laurence Sperling, MD a, Salim S. Virani, MD, PhD d
a Department of Cardiology, Emory University, Atlanta, Ga 
b Department of Medicine, University of Mississippi Medical Center, Jackson 
c Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass 
d Department of Cardiology, Baylor College of Medicine, Houston, Texas 
e Department of Cardiology, Houston Methodist Hospital, Texas 
f Department of Cardiology, Duke University, Durham, NC 
g Department of Cardiology, Johns Hopkins University, Baltimore, Md 
h VCU Health Pauley Heart Center, Virginia Commonwealth University School of Medicine, Richmond 
i Division of Cardiology, NorthShore University Hospital, Evanston, Ill 
j University of Texas Medical Branch, Galveston 

Requests for reprints should be addressed to Abdul Mannan Khan Minhas, MD, Department of Medicine, University of Mississippi Medical Center, 2500 N State, Jackson, MS 39402.Department of MedicineUniversity of Mississippi Medical Center2500 N StateJacksonMS39402

Abstract

Objective

The purpose of this research was to study the contemporary trends in cardiovascular disease (CVD) and diabetes mellitus (DM)-related mortality.

Methods

We used the Centers for Disease Control and Prevention Wide-Ranging OnLine Data for Epidemiologic Research (CDC WONDER) database to identify adults ≥25 years old where both CVD and DM were listed as an underlying or contributing cause of death between 1999 and 2019. Crude and age-adjusted mortality rates per 100,000 population were determined.

Results

The overall age-adjusted mortality rate was 99.18 in 1999 and 91.43 in 2019, with a recent increase from 2014-2019 (annual percent change 1.0; 95% confidence interval [CI], 0.3-1.6). Age-adjusted mortality rate was higher for males compared with females, with increasing mortality in males between 2014 and 2019 (annual percent change 1.5; 95% CI, 0.9-2.0). Age-adjusted mortality rate was highest for non-Hispanic Black adults and was ∼2-fold higher compared with non-Hispanic White adults. Young and middle-aged adults (25-69 years) had increasing age-adjusted mortality rates in recent years. There were significant urban-rural disparities, and age-adjusted mortality rates in rural counties increased from 2014 to 2019 (annual percent change 2.2; 95% CI, 1.5-2.9); states in the 90th percentile of mortality had age-adjusted mortality rates that were ∼2-fold higher than those in the bottom 10th percentile of mortality.

Conclusion

After an initial decrease in DM + CVD-related mortality for a decade, this trend has reversed, with increasing mortality from 2014 to 2019. Significant geographic and demographic disparities persist, requiring targeted health policy interventions to prevent the loss of years of progress.

Le texte complet de cet article est disponible en PDF.

Keywords : Cardiovascular diseases, Diabetes mellitus, Health care disparities, Mortality trends


Plan


 Funding: None.
 Conflicts of Interest: All authors declare that they do not have any conflict of interests relevant to the manuscript.
 Authorship: All authors had access to all the study data and take responsibility for manuscript submission.


© 2023  Elsevier Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 136 - N° 7

P. 659 - juillet 2023 Retour au numéro
Article précédent Article précédent
  • Extensive Palpable Purpura Preceding Renal Dysfunction in Immunoglobulin A Vasculitis Due to Coronavirus-19 Infection
  • Carolyn G. Ahlers, Bangchen Wang, David N. Howell, Vinay Choksi
| Article suivant Article suivant
  • Cardiovascular Disease Risk and Statin Use Among Adults with Metabolic Dysfunction Associated Fatty Liver Disease
  • Aaron Yeoh, Ramsey Cheung, Aijaz Ahmed, Amit S. Chitnis, Albert Do, Robert J. Wong

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.